Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prediction of the Binding Affinities and Selectivity for CB1 and CB2 Ligands Using Homology Modeling, Molecular Docking, Molecular Dynamics Simulations, and MM-PBSA Binding Free Energy Calculations
Beihong Ji, Shuhan Liu, Xibing He, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 8, pp. 1139-1158
Closed Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Recent Developments in Free Energy Calculations for Drug Discovery
Edward J. King, Erick Aitchison, Han Li, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 92
Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future
Zak M. Whiting, Jiazhen Yin, Sara M. de la Harpe, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 9, pp. 754-771
Closed Access | Times Cited: 40
Identification of Novel Dipeptidyl Peptidase-IV Inhibitory Peptides in Chickpea Protein Hydrolysates
Rong Zan, Qiming Wu, Yi‐Ling Chen, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 21, pp. 8211-8219
Closed Access | Times Cited: 22
Screening and evaluation of novel DPP-IV inhibitory peptides in goat milk based on molecular docking and molecular dynamics simulation
Kuo Dang, Jing Lan, Yanli Wang, et al.
Food Chemistry X (2025), pp. 102217-102217
Open Access | Times Cited: 1
Mechanistic Understanding from Molecular Dynamics in Pharmaceutical Research 2: Lipid Membrane in Drug Design
Tomasz Róg, Mykhailo Girych, Alex Bunker
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 1062-1062
Open Access | Times Cited: 43
Dipeptidyl peptidase-IV inhibitory activity of millet protein peptides and the related mechanisms revealed by molecular docking
Haofeng Gu, Jing Gao, Qun Shen, et al.
LWT (2020) Vol. 138, pp. 110587-110587
Closed Access | Times Cited: 45
Some Flavolignans as Potent Sars-Cov-2 Inhibitors via Molecular Docking, Molecular Dynamic Simulations and ADME Analysis
Adnan Çetin
Current Computer - Aided Drug Design (2022) Vol. 18, Iss. 5, pp. 337-346
Closed Access | Times Cited: 22
Structural and functional insights into the G protein-coupled receptors: CB1 and CB2
Christina A. Brust, Matthew A. Swanson, Laura Bohn
Biochemical Society Transactions (2023) Vol. 51, Iss. 4, pp. 1533-1543
Open Access | Times Cited: 13
SuanZaoRen decoction alleviates neuronal loss, synaptic damage and ferroptosis of AD via activating DJ-1/Nrf2 signaling pathway
Qinghua Long, T. T. Li, Qihang Zhu, et al.
Journal of Ethnopharmacology (2023) Vol. 323, pp. 117679-117679
Open Access | Times Cited: 13
Virtual screening using docking and molecular dynamics of cannabinoid analogs against CB1 and CB2 receptors
Antistio Aviz-Amador, Neyder Contreras‐Puentes, Jairo Mercado‐Camargo
Computational Biology and Chemistry (2021) Vol. 95, pp. 107590-107590
Closed Access | Times Cited: 29
In silico studies on stilbenolignan analogues as SARS-CoV-2 Mpro inhibitors
Adnan Çetin
Chemical Physics Letters (2021) Vol. 771, pp. 138563-138563
Open Access | Times Cited: 28
Identification of Novel Cathepsin B Inhibitors with Implications in Alzheimer’s Disease: Computational Refining and Biochemical Evaluation
Nitin Chitranshi, Ashutosh Kumar, S. Sheriff, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 1946-1946
Open Access | Times Cited: 25
Recent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and their Therapeutic Potential
Valeria Gasperi, Tatiana Guzzo, Alessandra Topai, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 12, pp. 1420-1457
Closed Access | Times Cited: 18
Structures of adenosine receptor A2BR bound to endogenous and synthetic agonists
Hongmin Cai, Youwei Xu, Shimeng Guo, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 18
Recent Advances in Endocannabinoid System Targeting for Improved Specificity: Strategic Approaches to Targeted Drug Delivery
Mendhi Henna Dasram, Roderick B. Walker, Sandile M. Khamanga
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13223-13223
Open Access | Times Cited: 16
Estrogenic disruption effects and formation mechanisms of transformation products during photolysis of preservative parabens
Guanhui Chen, Xiaolin Niu, Yi Chen, et al.
The Science of The Total Environment (2024) Vol. 924, pp. 171608-171608
Closed Access | Times Cited: 3
Unraveling the Mechanisms of Cannabidiol’s Pharmacological Actions: A Comprehensive Research Overview
Iqra Kalsoom, Kiran Shehzadi, Hansheng Li, et al.
Topics in Current Chemistry (2024) Vol. 382, Iss. 2
Closed Access | Times Cited: 3
Identification of Novel CB2 Ligands through Virtual Screening and In Vitro Evaluation
Adam Stasiulewicz, Anna Leśniak, Magdalena Bujalska‐Zadrożny, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 3, pp. 1012-1027
Open Access | Times Cited: 8
Physicochemical stability study of protein–benzoic acid complexes using molecular dynamics simulations
Mahreen Arooj, Ihsan A. Shehadi, Chahlaa Nassab, et al.
Amino Acids (2020) Vol. 52, Iss. 9, pp. 1353-1362
Closed Access | Times Cited: 22
Targeting Transcriptional CDKs 7, 8, and 9 with Anilinopyrimidine Derivatives as Anticancer Agents: Design, Synthesis, Biological Evaluation and In Silico Studies
Razan Eskandrani, Lamees S. Al-Rasheed, Siddique Akber Ansari, et al.
Molecules (2023) Vol. 28, Iss. 11, pp. 4271-4271
Open Access | Times Cited: 7
A Multi-target Drug Designing for BTK, MMP9, Proteasome and TAK1 for the Clinical Treatment of Mantle Cell Lymphoma
Shahrukh Qureshi, Ravina Khandelwal, Maddala Madhavi, et al.
Current Topics in Medicinal Chemistry (2021) Vol. 21, Iss. 9, pp. 790-818
Closed Access | Times Cited: 16
Antiviral activity of some benzo[g]quinazolines against coxsackievirus B4: biological screening and docking study
Hatem A. Abuelizz, Ahmed H. Bakheit, Mohamed Marzouk, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 4, pp. 962-978
Open Access | Times Cited: 6
Computational Insight into Biotransformation Profiles of Organophosphorus Flame Retardants to Their Diester Metabolites by Cytochrome P450
Yue Jia, Tingji Yao, Guangcai Ma, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2799-2799
Open Access | Times Cited: 10
Decoding the Molecular Dance: In Silico Exploration of Cannabinoid Interactions with Key Protein Targets for Therapeutic Insights
Maite L. Docampo Palacios, Giovanni A. Ramirez, Tesfay Tesfatsion, et al.
(2024)
Open Access | Times Cited: 1
A mechanistic model explaining ligand affinity for, and partial agonism of, cannabinoid receptor 1
Fred Shahbazi, Daniel Meister, Sanam Mohammadzadeh, et al.
(2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top